Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

FRAGRANCE CREATORS ASSOCIATION

Filed by ARENTFOX SCHIFF LLP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 21, 2025
Income
$20,000.00
Expenses
Not reported
Filing UUID
e1a67010-9c60-42e7-a686-7c3b5680d016
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

CSP · Consumer Issues/Safety/Products

Implementation of Modernization of Cosmetics Regulation Act (MOCRA) regarding cosmetics ingredients and products Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.

TAX · Taxation/Internal Revenue Code

Policies related to corporate taxes and tax incentives, including research and experimentation expensing Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.

BUD · Budget/Appropriations

Fiscal Year 2026 Department of Agriculture funding regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA)FY26 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, Title VI, regarding implementation of Modernization of Cosmetics Regulation Act (MOCRA) Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.

CHM · Chemicals/Chemical Industry

Implementation of P.L. 114-182 (Frank R. Lautenberg Chemical Safety for the 21st Century Act), regarding provisions related to the approval of new chemicals and risk evaluations Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.